KEY FINDINGS
The North America influenza vaccine market is anticipated to reach a CAGR of 6.06% over the projected period of 2020-2028. The growing number of cases of influenza is one of the significant factors augmenting market growth in the region.
MARKET INSIGHTS
The North America influenza vaccine market is further surveyed by segregating the region into the United States and Canada. In Canada, according to the experts, a type of influenza B had started circulating at the same rate as influenza A at the end of 2019, which is unusual as influenza B does not circulate until late in the season. This has caused concern among the experts as influenza B leads to a higher risk of hospitalization and deaths among children. The recent Flu Watch report published by PHAC in January 2020 explains the link between increased presence of influenza B and higher pediatric illnesses and hospitalizations. As per the PHAC, a similar number of pediatric hospitalizations due to influenza A were reported this season as compared to previous years. In Canada, the funding for childhood and adult immunization programs for influenza vaccines is different. Most of the pediatric immunization programs are publicly funded through public health programs and physician offices. Public funding for adults is limited, and patients often request for vaccines from their healthcare providers and physician offices. Moreover, certain vaccines are covered under private insurance plans or by the employer, specifically those recommended for specific risk situations such as occupation or travel, and are not publically funded.
COMPETITIVE INSIGHTS
Pfizer Inc, Abbott, Merck, Emergent Biosolutions, CSL Ltd, etc. are some of the renowned companies operating in the market.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
North America Influenza Vaccine Market Forecast 2020-2028
Table of Contents
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates `
2.2. Market Overview
3. Market Dynamics
3.1. Parent Market Analysis: Vaccine Market
3.2. Market Definition
3.3. Key Drivers
3.3.1. Government Immunization Programs To Eradicate Ailments From The Society
3.3.2. Rise In The Cases Of Influenza
3.3.3. Technology Advancement
3.4. Key Restraints
3.4.1. High Cost Of Development
3.4.2. Lengthy Process Of Development
4. Key Analytics
4.1. Key Investment Insights
4.2. Porter's Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape
5. Market By Type
5.1. Quadrivalent Vaccine
5.2. Trivalent Vaccine
6. Market By Technology
6.1. Egg-Based Technology
6.2. Cell-Based Technology
7. Market By Age Group
7.1. Pediatric Age Group
7.2. Adult Age Group
8. Market By Delivery Mode
8.1. Injection
8.2. Nasal Spray
9. Geographical Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
10. Company Profiles
10.1. Merck
10.2. Novartis Ag
10.3. Pfizer Inc
10.4. Sanofi
10.5. Biodiem
10.6. Emergent Biosolutions
10.7. F. Hoffmann-La Roche Ltd
10.8. Glaxosmithkline
10.9. Abbott
10.10. Csl Ltd
List of Tables
Table 1: Market Snapshot - Influenza Vaccine
Table 2: North America Influenza Vaccine Market, By Type, Historical Years, 2016-2019 (In $ Million)
Table 3: North America Influenza Vaccine Market, By Type, Forecast Years, 2020-2028 (In $ Million)
Table 4: North America Influenza Vaccine Market, By Technology, Historical Years, 2016-2019 (In $ Million)
Table 5: North America Influenza Vaccine Market, By Technology, Forecast Years, 2020-2028 (In $ Million)
Table 6: North America Influenza Vaccine Market, By Age Group, Historical Years, 2016-2019 (In $ Million)
Table 7: North America Influenza Vaccine Market, By Age Group, Forecast Years, 2020-2028 (In $ Million)
Table 8: North America Influenza Vaccine Market, By Delivery Mode, Historical Years, 2016-2019 (In $ Million)
Table 9: North America Influenza Vaccine Market, By Delivery Mode, Forecast Years, 2020-2028 (In $ Million)
Table 10: North America Influenza Vaccine Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 11: North America Influenza Vaccine Market, By Country, Forecast Years, 2020-2028 (In $ Million)
List of Figures
Figure 1: Key Investment Insights
Figure 2: Porter's Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: North America Influenza Vaccine Market, Growth Potential, By Type, In 2019
Figure 6: North America Influenza Vaccine Market, By Quadrivalent Vaccine, 2020-2028 (In $ Million)
Figure 7: North America Influenza Vaccine Market, By Trivalent Vaccine, 2020-2028 (In $ Million)
Figure 8: North America Influenza Vaccine Market, Growth Potential, By Technology, In 2019
Figure 9: North America Influenza Vaccine Market, By Egg-Based Technology, 2020-2028 (In $ Million)
Figure 10: North America Influenza Vaccine Market, By Cell-Based Technology, 2020-2028 (In $ Million)
Figure 11: North America Influenza Vaccine Market, Growth Potential, By Age Group, In 2019
Figure 12: North America Influenza Vaccine Market, By Pediatric Age Group, 2020-2028 (In $ Million)
Figure 13: North America Influenza Vaccine Market, By Adult Age Group, 2020-2028 (In $ Million)
Figure 14: North America Influenza Vaccine Market, Growth Potential, By Delivery Mode, In 2019
Figure 15: North America Influenza Vaccine Market, By Injection, 2020-2028 (In $ Million)
Figure 16: North America Influenza Vaccine Market, By Nasal Spray, 2020-2028 (In $ Million)
Figure 17: North America Influenza Vaccine Market, Regional Outlook, 2019 & 2028 (In %)
Figure 18: United States Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 19: Canada Influenza Vaccine Market, 2020-2028 (In $ Million)
Global Encephalitis Vaccination Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 102
According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period.
The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 123
Market Overview of Global Avian Influenza Vaccines market:
According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years.
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 96
According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period.
The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
Global Avian Influenza Vaccines Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 155
According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period.
The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 28-Dec-2023 Price: US 3380 Onwards Pages: 106
Market Overview of Global Encephalitis Vaccination market:
According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
Global Influenza Vaccine Market Research Report 2023
Published: 28-Dec-2023 Price: US 2900 Onwards Pages: 96
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- BCHT
- Jiangsu G......
Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 117
Market Overview of Global Japanese Encephalitis Vaccine market:
According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 14-Dec-2023 Price: US 3380 Onwards Pages: 103
Market Overview of Global Influenza Vaccine market:
According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses...
......
2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
Published: 11-Dec-2023 Price: US 2500 Onwards Pages: 107
This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Influenza Vaccine from......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
